Exagen(XGN)

1.93 -0.005 -0.2584%

今开:1.94昨收:1.935
最高:1.9649 最低:1.9
涨停价:0.0跌停价:0.0
总市值:3.353082E7

Exagen的热门讨论

持股变动声明

Exagen(XGN)05-17 08:05

$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000052  Size: 5 KB 网页链接查看全文

季度财报

Exagen(XGN)05-13 21:35

$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-24-000048  Act: 34  Size: 4 MB 网页链接查看全文

持股变动声明

Exagen(XGN)06-13 04:15

$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000062  Size: 5 KB 网页链接查看全文

股东委托书协议

Exagen(XGN)04-26 20:35

$Exagen(XGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001274737-24-000028  Act: 34  Size: 1 MB 网页链接查看全文

其他

Exagen(XGN)04-26 21:25

$Exagen(XGN)$ ARS Annual Report to Security Holders Accession Number: 0001274737-24-000037  Act: 34  Size: 13 MB 网页链接查看全文

当期报告

Exagen(XGN)05-13 20:05

$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-24-000045  Act: 34  Size: 300 KB 网页链接查看全文

持股变动声明

Exagen(XGN)06-13 04:15

$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000061  Size: 5 KB 网页链接查看全文

当期报告

Exagen(XGN)06-12 04:15

$Exagen(XGN)$ 8-K Current report, item 5.07 Accession Number: 0001274737-24-000056  Act: 34  Size: 159 KB 网页链接查看全文

当期报告

Exagen(XGN)04-26 20:35

$Exagen(XGN)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001274737-24-000030  Act: 34  Size: 188 KB 网页链接查看全文

持股变动声明

Exagen(XGN)06-13 04:15

$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000063  Size: 5 KB 网页链接查看全文

1 2

Exagen的最新讨论

TOPVIEW | 2021.8.11Bio-market主要涨跌一览

蹊之美股生物医药2021-08-12 03:35

作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文

Exagen的公告

超过5%股东持股披露「修订」

$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-23-000185  Act: 34  Size: 30 KB 网页链接

超过5%股东持股披露「修订」

$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-23-000139  Act: 34  Size: 60 KB 网页链接

持股变动声明

$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-23-000007  Size: 4 KB 网页链接

持股变动声明

$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-23-000008  Size: 4 KB 网页链接

超过5%股东持股披露「修订」

$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000814133-23-000044  Act: 34  Size: 3 KB 网页链接

超过5%股东持股披露「修订」

$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-23-008860  Act: 34  Size: 194 KB 网页链接

超过5%股东持股披露「修订」

$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001085146-23-000656  Act: 34  Size: 54 KB 网页链接

超过5%股东持股披露「修订」

$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001140361-23-004169  Act: 34  Size: 82 KB 网页链接

超过5%股东持股披露「修订」

$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001085146-23-000295  Act: 34  Size: 27 KB 网页链接

当期报告

$Exagen(XGN)$ 8-K Current report, items 5.03, 7.01, and 9.01 Accession Number: 0001274737-23-000004  Act: 34  Size: 210 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29